将白细胞介素-7基因转移至转移性结肠癌、肾细胞癌、黑色素瘤或淋巴瘤患者体内。 - Suppr | 超能文献

Interleukin-7 gene transfer in patients with metastatic colon carcinoma, renal cell carcinoma, melanoma, or with lymphoma.

作者信息

Schmidt-Wolf I G, Huhn D, Neubauer A, Wittig B

出版信息

Hum Gene Ther. 1994 Sep;5(9):1161-8. doi: 10.1089/hum.1994.5.9-1161.

DOI:10.1089/hum.1994.5.9-1161

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Interleukin-7 gene transfer in patients with metastatic colon carcinoma, renal cell carcinoma, melanoma, or with lymphoma.将白细胞介素-7基因转移至转移性结肠癌、肾细胞癌、黑色素瘤或淋巴瘤患者体内。

Hum Gene Ther. 1994 Sep;5(9):1161-8. doi: 10.1089/hum.1994.5.9-1161.

2

Therapeutic vaccination against metastatic carcinoma by expression-modulated and immunomodified autologous tumor cells: a first clinical phase I/II trial.通过表达调控和免疫调节的自体肿瘤细胞进行转移性癌的治疗性疫苗接种：首个临床I/II期试验

Hum Gene Ther. 2001 Feb 10;12(3):267-78. doi: 10.1089/10430340150218404.

3

Enhancement of interleukin-2-induced lymphokine-activated killer activity by interleukin 7 against autologous human renal cell carcinoma.白细胞介素7增强白细胞介素2诱导的针对自体人肾细胞癌的淋巴因子激活的杀伤活性

Oncology. 1998 Nov-Dec;55(6):588-93. doi: 10.1159/000011917.

4

Cellular therapy: scientific rationale and clinical results in the treatment of metastatic renal-cell carcinoma.细胞疗法：转移性肾细胞癌治疗的科学原理与临床结果

Semin Oncol. 1995 Feb;22(1):74-80.

5

Immunohistochemical correlates of response to recombinant interleukin-2-based immunotherapy in humans.人类中基于重组白细胞介素-2免疫疗法反应的免疫组织化学相关性

Cancer Res. 1989 Dec 15;49(24 Pt 1):7086-92.

6

In vivo activation of LAK cells during systemic IL-2 therapy.全身应用白细胞介素-2治疗期间LAK细胞的体内激活

Eur Cytokine Netw. 1990 Aug-Sep;1(3):185-8.

7

Adoptive cellular therapy.过继性细胞疗法

Cancer Chemother Biol Response Modif. 1991;12:213-30.

8

[Lymphokine-activated killer cell adoptive immunotherapy for cancer treatment and its significance].[淋巴因子激活的杀伤细胞过继性免疫疗法治疗癌症及其意义]

Hum Cell. 1992 Sep;5(3):218-25.

9

Randomized study of interleukin 2 (IL-2) alone vs IL-2 plus lymphokine-activated killer cells for treatment of melanoma and renal cell cancer.白细胞介素-2（IL-2）单独治疗与IL-2联合淋巴因子激活的杀伤细胞治疗黑色素瘤和肾细胞癌的随机研究。

Arch Surg. 1991 Jul;126(7):898-903. doi: 10.1001/archsurg.1991.01410310108017.

10

Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer.对转移性癌症患者进行自体淋巴因子激活的杀伤细胞和重组白细胞介素-2全身给药的观察。

N Engl J Med. 1985 Dec 5;313(23):1485-92. doi: 10.1056/NEJM198512053132327.

引用本文的文献

1

Generation of dendritic cell-based vaccines for cancer therapy.用于癌症治疗的基于树突状细胞的疫苗的研发。

Br J Cancer. 2002 May 20;86(10):1529-33. doi: 10.1038/sj.bjc.6600316.

2

Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma.白细胞介素-2基因转染的自体免疫效应细胞应用于转移性肾癌、结直肠癌和淋巴瘤患者的I期临床研究。

Br J Cancer. 1999 Nov;81(6):1009-16. doi: 10.1038/sj.bjc.6690800.